SECURITIES AND EXCHANGE COMMISSION
Washington, DC20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 12, 2012
Commission File Number:
000-53750
PROTEONOMIX, INC.
(Name of Registrant in Its Charter)
|
|
|
|
|
|
Delaware
(State or Other Jurisdiction ofIncorporation or Organization)
|
45-5185575
(I.R.S. Employer Identification No.)
|
145 Highview Terrace, Hawthorne, NJ 07506
(Address of Principal Executive Offices) (Zip Code)
(973) 544-6116
(Issuer
’
s Telephone Number, Including Area Code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM4.01CHANGES IN REGISTRANT
’
S CERTIFYING ACCOUNTNAT
Previous independent registered public accounting firm
On May 21, 2012, Proteonomix, Inc. (the
“
Registrant
”
or the
“
Company
”
) was notified by Demetrius & Company, L.L.C. (
“
Demetrius
”
) that they have resigned as the Registrant
’
s independent registered public accounting firm. This resignation was the subject of a Form 8-K filed May 25, 2012.
New independent registered public accounting firm
On June 8, 2012 (the
“
Engagement Date
”
), the Company engaged Manela & Co. (
“
Manela
”
) as its independent registered public accounting firm. The decision to engage Manela as the Company
’
s independent registered public accounting firm was approved by the Company
’
s Board of Directors.
During the years ended December 31, 2011 and 2010, and through May 11, 2012, (the date Demetrius was appointed), the Company did not consult Demetrius with respect to the application of accounting principles to any specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company
’
s Financial Statements, or any other matters or reportable events as defined in Item 304(a)(2)(i) and (ii) of Regulation S-K.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(a)
Financial statements of business acquired.
Not applicable
(b)
Pro forma financial information.
Not applicable
(c)
Shell company transactions.
Not applicable
(d)
Exhibits
None
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PROTEONOMIX, INC.
Dated: June 12, 2012
By:
/s/Michael Cohen
Name: Michael Cohen
President
